Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts

Cardiac fibroblasts (CF) play a key role in orchestrating the structural remodeling of the myocardium in response to injury or stress, in part through direct regulation of extracellular matrix (ECM) turnover. The matrix metalloproteinases (MMPs) are a family of over 25 zinc‐dependent proteases that together have the capacity to degrade all the protein components of the ECM. Fibroblasts are a major source of several MMPs in the heart, thereby representing a viable therapeutic target for regulating ECM turnover in cardiac pathologies characterized by adverse remodeling, such as myocardial infarction, cardiomyopathy, hypertension and heart failure. This review summarizes current knowledge on the identity and regulation of MMPs expressed by CF and discusses future directions for reducing adverse myocardial remodeling by modulating the expression and/or activity of CF‐derived MMPs. © 2012 IUBMB IUBMB Life, 2012.

[1]  M. Lindsey,et al.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. , 2012, Cardiovascular therapeutics.

[2]  N. Turner.  Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways. , 2011, Future cardiology.

[3]  F. Spinale,et al.  Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling. , 2011, American journal of physiology. Heart and circulatory physiology.

[4]  F. Thong,et al.  Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. , 2011, Endocrinology.

[5]  E. Olson,et al.  Pervasive roles of microRNAs in cardiovascular biology , 2011, Nature.

[6]  J. Penninger,et al.  Loss of PI3K&ggr; Enhances cAMP-Dependent MMP Remodeling of the Myocardial N-Cadherin Adhesion Complexes and Extracellular Matrix in Response to Early Biomechanical Stress , 2010, Circulation research.

[7]  S. Kauppinen,et al.  Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. , 2010, The Journal of clinical investigation.

[8]  S. Ball,et al.  Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: Role of p38 MAP kinase , 2010, Matrix biology : journal of the International Society for Matrix Biology.

[9]  Christine N. Koval,et al.  Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction* , 2010, The Journal of Biological Chemistry.

[10]  H. Zhang,et al.  Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling , 2010, Journal of cellular and molecular medicine.

[11]  J. Penninger,et al.  Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. , 2010, American journal of physiology. Cell physiology.

[12]  R. Schulz,et al.  Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. , 2010, Cardiovascular research.

[13]  S. Ball,et al.  Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts , 2009, Journal of molecular and cellular cardiology.

[14]  N. Turner,et al.  Cardiac fibroblasts: at the heart of myocardial remodeling. , 2009, Pharmacology & therapeutics.

[15]  G. Nuovo,et al.  MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. , 2009, Cardiovascular research.

[16]  W. Rottbauer,et al.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.

[17]  J. D’Armiento,et al.  Transgenic Expression of Matrix Metalloproteinase-1 Inhibits Myocardial Fibrosis and Prevents the Transition to Heart Failure in a Pressure Overload Mouse Model , 2008, Hypertension Research.

[18]  M. Stack,et al.  Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. , 2008, Seminars in cell & developmental biology.

[19]  M. Feldman,et al.  IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation , 2007 .

[20]  C. Brinckerhoff,et al.  Signal transduction and cell‐type specific regulation of matrix metalloproteinase gene expression: Can MMPs be good for you? , 2007, Journal of cellular physiology.

[21]  C. Long,et al.  Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. , 2007, Biochemical and biophysical research communications.

[22]  Francis G Spinale,et al.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.

[23]  J. Ikonomidis,et al.  Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy. , 2007, American journal of physiology. Cell physiology.

[24]  S. Ball,et al.  Simvastatin inhibits TNFα-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms , 2007 .

[25]  D. Boyd,et al.  Regulation of matrix metalloproteinase gene expression , 2007, Journal of cellular physiology.

[26]  M. Fini,et al.  Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. , 2006, American journal of physiology. Heart and circulatory physiology.

[27]  J. S. Janicki,et al.  The relationship between myocardial extracellular matrix remodeling and ventricular function. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  Mario J. Garcia,et al.  Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. , 2006, Journal of the American College of Cardiology.

[29]  Merry L. Lindsey,et al.  Matrix Metalloproteinase-7 Affects Connexin-43 Levels, Electrical Conduction, and Survival After Myocardial Infarction , 2006, Circulation.

[30]  M. Schellings,et al.  Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. , 2006, Cardiovascular research.

[31]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[32]  J. Saul,et al.  Time-dependent changes in myocardial structure following discrete injury in mice deficient of matrix metalloproteinase-3. , 2005, Journal of molecular and cellular cardiology.

[33]  F. Spinale,et al.  Trafficking of the Membrane Type-1 Matrix Metalloproteinase in Ischemia and Reperfusion: Relation to Interstitial Membrane Type-1 Matrix Metalloproteinase Activity , 2005, Circulation.

[34]  B. Thiele,et al.  Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia. , 2004, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[35]  Zhonglin Xie,et al.  Differential Regulation of Matrix Metalloproteinase-2 and -9 Expression and Activity in Adult Rat Cardiac Fibroblasts in Response to Interleukin-1β* , 2004, Journal of Biological Chemistry.

[36]  S. Rosenkranz.  TGF-β1 and angiotensin networking in cardiac remodeling , 2004 .

[37]  E. Fleck,et al.  Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase. , 2004, Cardiovascular research.

[38]  Chun Guo,et al.  Type I Collagen-induced MMP-2 Activation Coincides with Up-regulation of Membrane Type 1-Matrix Metalloproteinase and TIMP-2 in Cardiac Fibroblasts* , 2003, Journal of Biological Chemistry.

[39]  F. Spinale,et al.  Selective Targeting and Timing of Matrix Metalloproteinase Inhibition in Post-Myocardial Infarction Remodeling , 2003, Circulation.

[40]  Richard T. Lee,et al.  Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction , 2002, Circulation.

[41]  V. Quesada,et al.  Identification and Enzymatic Characterization of Two Diverging Murine Counterparts of Human Interstitial Collagenase (MMP-1) Expressed at Sites of Embryo Implantation* , 2001, The Journal of Biological Chemistry.

[42]  Y. Liu,et al.  Yeast Nuclear Extract Contains Two Major Forms of RNA Polymerase II Mediator Complexes* , 2001, The Journal of Biological Chemistry.

[43]  J. D’Armiento,et al.  Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. , 2000, The Journal of clinical investigation.

[44]  S. Weiss,et al.  Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. , 2000, Molecular biology of the cell.

[45]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[46]  A. Feldman,et al.  Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. , 1999, Cardiovascular research.

[47]  K. Weber,et al.  Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.

[48]  D. Gingras,et al.  Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. , 2010, Biochimica et biophysica acta.

[49]  Johan Verjans,et al.  Myocardial remodeling after infarction: the role of myofibroblasts , 2010, Nature Reviews Cardiology.

[50]  C. Overall,et al.  Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. , 2010, Biochimica et biophysica acta.

[51]  E. Creemers,et al.  Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[52]  Jingfeng Wang,et al.  Transcription factor decoys for activator protein-1 (AP-1) inhibit oxidative stress-induced proliferation and matrix metalloproteinases in rat cardiac fibroblasts. , 2009, Translational research : the journal of laboratory and clinical medicine.

[53]  C. Brinckerhoff,et al.  Transforming growth factor beta inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription. , 2000, Biochimica et biophysica acta.